Perritt Capital Management’s MGC Diagnostics Corporation MGCD Stock Holding History

Perritt Capital Management’s Portfolio MGCD Stock Details MGCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-70,000	Closed	-$628K	–	240
2017 Q3	$628K	Hold	70,000	–	–	0.17%	152
2017 Q2	$574K	Hold	70,000	–	–	0.15%	157
2017 Q1	$585K	Hold	70,000	–	–	0.15%	146
2016 Q4	$552K	Hold	70,000	–	–	0.13%	143
2016 Q3	$490K	Buy	70,000 +12,417	+22%	+$85.7K	0.12%	165
2016 Q2	$375K	Buy	57,583 +5,342	+10%	+$31.9K	0.1%	184
2016 Q1	$320K	Buy	+52,241	New	+$344K	0.08%	197
2014 Q3	–	Sell	-70,800	Closed	-$588K	–	263
2014 Q2	$588K	Sell	70,800 -5,750	-8%	-$56.9K	0.1%	202
2014 Q1	$872K	Buy	76,550 +6,300	+9%	+$71.2K	0.14%	167
2013 Q4	$889K	Hold	70,250	–	–	0.15%	143
2013 Q3	$769K	Buy	70,250 +17,000	+32%	+$153K	0.15%	134
2013 Q2	$445K	Buy	+53,250	New	+$387K	0.1%	177

Other funds holding MGCD

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

JIR

James Investment Research Alpha, Ohio $891M AUM 30.4% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Perritt Capital Management's MGCD Position: Q4 2017 in Review

Perritt Capital Management sold out of MGC Diagnostics Corporation (MGCD) in Q4 2017, closing a stake of 70,000 shares — an estimated $628K sold.

Perritt Capital Management first reported a position in MGCD in Q2 2013 and held it in 12 quarters. The position peaked at $889K in Q4 2013. 12 funds tracked by Wall St. Rank hold MGCD as of Q4 2017.

Perritt Capital Management reported no remaining MGC Diagnostics Corporation position as of Q4 2017 after selling out during the quarter.
Perritt Capital Management sold 70,000 MGC Diagnostics Corporation shares in Q4 2017, an estimated $628K.
Perritt Capital Management first reported a position in MGC Diagnostics Corporation in Q2 2013 and held it in 12 quarters.
Perritt Capital Management's MGC Diagnostics Corporation position peaked at $889K in Q4 2013.
12 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q4 2017.

Based on Perritt Capital Management's 13F filing for Q4 2017, filed 25 Jan 2018.